Cargando…

Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy

Background: Progressive multifocal leukoencephalopathy (PML) is a viral disease characterized by progressive damage or inflammation of the cerebral white matter that can be encountered in patients with multiple sclerosis (MS). There are cases of PML caused by pharmacological agents including nataliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo Buono, Viviana, D’Aleo, Giangaetano, Cammaroto, Simona, De Cola, Maria Cristina, Palmese, Francesca, Smorto, Chiara, Marino, Silvia, Venuti, Giuseppe, Sessa, Edoardo, Rifici, Carmela, Corallo, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025511/ https://www.ncbi.nlm.nih.gov/pubmed/35454389 http://dx.doi.org/10.3390/medicina58040551

Ejemplares similares

The Relationship between Body Image, Disability and Mental Health in Patients with Multiple Sclerosis
por: Lo Buono, Viviana, et al.
Publicado: (2023)

Therapeutic adherence and coping strategies in patients with multiple sclerosis: An observational study
por: Corallo, Francesco, et al.
Publicado: (2019)

Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient: A case report
por: D’Aleo, Giangaetano, et al.
Publicado: (2020)

Acute exacerbation of Hashimoto's thyroiditis in a patient treated with dimethyl fumarate for multiple sclerosis: A case report
por: Ciurleo, Rosella, et al.
Publicado: (2019)

Impact of Depression, Fatigue, and Global Measure of Cortical Volume on Cognitive Impairment in Multiple Sclerosis
por: Nunnari, Domenica, et al.
Publicado: (2015)

Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
por: Russo, Margherita, et al.
Publicado: (2015)

The role of cognitive rehabilitation in limbic encephalitis: A case report
por: Corallo, Francesco, et al.
Publicado: (2018)

Psychological well-being in people with multiple sclerosis: a descriptive review of the effects obtained with mindfulness interventions
por: Di Cara, Marcella, et al.
Publicado: (2021)

Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study
por: Ciurleo, Rosella, et al.
Publicado: (2018)

Neuropsychological implication in possible antibody-negative limbic encephalitis: a clinical case report
por: Lo Buono, Viviana, et al.
Publicado: (2022)

Natalizumab: Progressive multifocal leukoencephalopathy: case report
Publicado: (2021)

Cognitive and Speech Rehabilitation in a Patient Affected by Takotsubo Cardiomyophathy: A Case Report
por: Corallo, Francesco, et al.
Publicado: (2022)

Audit as a Tool for Improving the Quality of Stroke Care: A Review
por: Cappadona, Irene, et al.
Publicado: (2023)

Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
por: Russo, Margherita, et al.
Publicado: (2015)

Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy
por: Dong-Si, Tuan, et al.
Publicado: (2015)

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
por: Toorop, Alyssa A., et al.
Publicado: (2020)

Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
por: Perkins, Molly R., et al.
Publicado: (2012)

Communication Training: Significance and Effects of a Preliminary Psychological Intervention upon an Audit Team
por: Cardile, Davide, et al.
Publicado: (2023)

Music Therapy in Global Aphasia: A Case Report
por: Piccolo, Adriana, et al.
Publicado: (2023)

Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis
por: Herold, Tina Rike, et al.
Publicado: (2012)

Natalizumab-associated Progressive Multifocal Leukoencephalopathy in Patients with Multiple Sclerosis: A Mini Review
por: Fayyaz, Muniba, et al.
Publicado: (2018)

Rehabilitation in atypical neurological disease: a case report
por: Corallo, Francesco, et al.
Publicado: (2022)

Changes in Brain Volumes Are Relevant during Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: Lessons from a Case Report
por: De Masi, Roberto, et al.
Publicado: (2022)

Coping and Quality of Life Differences between Emergency and Rehabilitation Healthcare Workers
por: Cardile, Davide, et al.
Publicado: (2023)

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
por: Metz, Imke, et al.
Publicado: (2011)

Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
por: McGuigan, C, et al.
Publicado: (2016)

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients
por: Dahlhaus, Stefanie, et al.
Publicado: (2013)

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry
por: Prosperini, Luca, et al.
Publicado: (2016)

Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review
por: Vivekanandan, Govinathan, et al.
Publicado: (2021)

Improving Knowledge of Audit and Feedback among Health Care Professionals in Sicily
por: Ielo, Augusto, et al.
Publicado: (2023)

Presymptomatic Diagnosis with MRI and Adequate Treatment Ameliorate the Outcome after Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
por: Lindå, Hans, et al.
Publicado: (2013)

Early Magnetic Resonance Detection of Natalizumab-Related Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Sclerosis
por: Manenti, Guglielmo, et al.
Publicado: (2013)

Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod
por: Sinnecker, Tim, et al.
Publicado: (2016)

Insight into Metabolic (1)H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions
por: Schneider, Ruth, et al.
Publicado: (2017)

Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML
por: Alleg, Manel, et al.
Publicado: (2020)

Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
por: Hartung, Hans-Peter, et al.
Publicado: (2021)

Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
por: Plavina, Tatiana, et al.
Publicado: (2014)

Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_un22bj9hons4mlv942k6o3794q